Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2012

01-03-2012 | Book Review

A Plea for Order in a Complex Disease—Answered

Adenocarcinoma of the Esophagogastric Junction, Paul M. Schneider (volume editor) in Recent Results in Cancer Research, P.M. Schlag, H.-J. Senn (series editors) (Springer Publishing, 191 pp., $XX.XX)

Author: Blair A. Jobe

Published in: Journal of Gastrointestinal Cancer | Issue 1/2012

Login to get access

Excerpt

Likely because of its relative rarity, our understanding of esophageal cancer has suffered from a lack of resolution related to the inappropriate grouping of the different types and locations of malignancy into one “grab bag.” Richard R. Grant said that “the value of identity of course is that so often with it comes purpose.” Adenocarcinoma of the Esophagogastric Junction provides today’s most comprehensive and tailored description of the pathogenesis, diagnosis, staging, and therapy of malignancy of a single region within the upper digestive tract. The definition of the esophagogastric junction is defined in this text as a 10-cm region of territory divided equally by the endoscopic cardia; while this purely anatomic description of tumor location (“Siewert Classification”) may blend somewhat different diseases (e.g., distal esophageal and proximal gastric adenocarcinoma) with separate pathophysiology, it has served as an integral component of our lexicon in this arena and heretofore enabled order to be established to this complex subject matter. Adenocarcinoma of the Esophagogastric Junction is a festschrift of sorts, honoring Dr. hc J. Rudiger Siewert who has been a primary thought leader in esophageal cancer over the past 30 years and served as mentor and/or inspiration to many of the authors in this book. The chapters are succinct and well written, and the topics follow a logical progression of thought. There are 15 chapters with each including multiple subsections that direct the reader through a distillation process of the most important concepts. Without being terse, the pertinent and clinically useful material is delivered in easy-to-understand and compressed form. Although there is a paucity of figures and images, and the ones that are present are of satisfactory quality, this fact likely contributes to the reasonable cost compared most other texts. Perhaps the most attractive aspect of Adenocarcinoma of the Esophagogastric Junction is that as one reads through, a sense of “order” is appreciated and this ultimately frames the barriers that exist in the care of these patients. I left this text with many new perspectives and a sense of “purpose.” …
Metadata
Title
A Plea for Order in a Complex Disease—Answered
Adenocarcinoma of the Esophagogastric Junction, Paul M. Schneider (volume editor) in Recent Results in Cancer Research, P.M. Schlag, H.-J. Senn (series editors) (Springer Publishing, 191 pp., $XX.XX)
Author
Blair A. Jobe
Publication date
01-03-2012
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2012
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-012-9363-8

Other articles of this Issue 1/2012

Journal of Gastrointestinal Cancer 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.